Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-031106

Options or other derivatives

  • Chief Financial Officer acquired 152,345 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Bellemin Jean-Marc · Chief Financial Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2024-03-01 Grant or award : show line 1 in the form Restricted Stock Units +105,470 105,470 D
2024-03-01 Grant or award : show line 2 in the form Restricted Stock Units +46,875 46,875 D
Loading xslF345X05/tm248017-2_4seq1.xml…